Table 2.
Characteristics of Inhaled Corticosteroid Users
| ICS User (Total 22,261) | ||
|---|---|---|
| n | % | |
| ICS cumulative dose | ||
| Mean (SD) | 132,315.7 (338,241.0) | |
| Medium (Q1, Q3) | 30,720 (15,000, 107,160) | |
| 1–15,000 μg | 5542 | 25.01 |
| 15,001–30,720 μg | 5925 | 26.73 |
| 30,721–107,160 μg | 5156 | 23.27 |
| > 107,610 μg | 5538 | 24.99 |
| ICS dose | ||
| Low | 13,477 | 60.81 |
| Medium | 7330 | 33.08 |
| High | 1354 | 6.11 |
| Type of ICS | ||
| Fluticasone propionate | 11,436 | 51.60 |
| Budesonide | 5062 | 22.80 |
| Beclomethasone | 2156 | 9.73 |
| Ciclesonide | 997 | 4.50 |
| Fluticasone furoate | 2520 | 11.37 |
Abbreviation: ICS, inhaled corticosteroid.